Abstract
A rating scale for tardive dyskinesia was developed, consisting of nearly all signs seen by two groups of investigators over a 5-year period. Thirty-four items were included in the scale with a possibility of writing in idiosyncratic signs. The scale was shown to have good reliability and validity in studies carried out by both the New York and Boston groups. It is recommended as a suitable instrument for describing the breadth of tardive dyskinesia syndrome and also for quantifying the disorder. A second scale, “the abbreviated dyskinesia scale”, contains 13 items which are more global than the items in the original scale. It also has been shown to be both reliable and valid. Its use is suited to situations requiring less extensively detailed assessments.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cole, J. O., Gardos, G., Tarsy, D., et al.; Drug trials in persistent dyskinesia, in press (1979)
Crane, G. E., Paulson, G.: Involuntary movements in a sample of chronic mental patients and their relation to the treatment with neuroleptics. Int. J. Neuropsychiatry 3, 286–291 (1967)
Faurbye, A., Rasch, P. J., Petersen, P. B., Brandborg, G., Pakkenberg, H.: Neurological symptoms in pharmacotherapy of psychoses. Acta Psychiatr. Scand. 40, 1027 (1964)
Gardos, G., Cole, J. O., Sniffin, C.: An evaluation of papaverine in tardive dyskinesia. J. Clin. Pharmacol. 16, 5–6 (1976)
Gardos, G., Sokol, M., Cole, J. O., Sniffin, C.: Eye color and tardive dyskinesia. Psychopharmacol. Bull. 2, 7–9 (1976b)
Gardos, G., Cole, J. O., LaBrie, R. A.: The assessment of tardive dyskinesia. Arch. Gen. Psychiatry 34, 1206–1212 (1977)
National Institute of Mental Health, Psychopharmacology Research Branch: Development of a dyskinetic movement scale. ECDEU Intercom. 4, 3–6 (1975)
Sigwald, J., Bouttier, D., Courvoisier, S.: Les accidents neurologiques des medications Neuroleptiques. Rev. Neurol. (Paris) 100, 553–595 (1959a)
Sigwald, J., Bouttier, D., Raymondeaud, C., Piot, C.: Quatre cas de dyskinesie facio-bucco-linguomasticatrice a evolution prolongee secondaire a un traitement par les neuroleptiques. Rev. Neurol. (Paris) 100, 751–755 (1959b)
Simpson, G. M., Angus, J. W. S.: A Rating Scale for Extrapyramidal Side Effects. Acta Psychiatr. Scand. (Suppl.) 212, 1970
Simpson, G. M., Branchey, M. H., Lee, J. H., Voitashevsky, A., Zoubok, B.: Lithium in tardive dyskinesia. Pharmakopsychiatr. Neuropsychopharmakol. 9, 76–80 (1976a)
Simpson, G. M., Shrivastava, R., Lee, J. H.: Clozapine in tardive dyskinesia. Psychopharmacology 56, 75–80 (1978)
Simpson, G. M., Voitashevsky, A., Young, M. A., Lee, J. H.: Deanol in the treatment of tardive dyskinesia. Psychopharmacology 52, 257–261 (1977)
Simpson, G. M., Zoubok, B., Lee, J. H.: An early clinical and toxicity trial of EX 11-582A in chronic schizophrenia. Curr. Ther. Res. 1, (1976b)
Schonecker, M.: Ein eigentümliches Syndrom im oralen Bereich bei Megaphen Applikation. Nervenarzt 28, 35 (1957)
Uhrbrand, L., Faurbye, A.: Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine and electroconvulsive therapy. Psychopharmacologia (Berl.) 1, 408–418 (1960)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Simpson, G.M., Lee, J.H., Zoubok, B. et al. A rating scale for tardive dyskinesia. Psychopharmacology 64, 171–179 (1979). https://doi.org/10.1007/BF00496058
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00496058